Evidence map›Paper›PMID 40548086›Full record

ArticleApplied biosafety : journal of the American Biological Safety Association2025

The World Needs a PEPP Policy that Addresses Biosafety Loopholes Highlighted by the COVID-19 Pandemic.

Alina Chan

Abstract read
In one paragraph

Article in Applied biosafety : journal of the American Biological Safety Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Alina ChanBroad Institute of MIT & Harvard, Cambridge, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The new U.S. government policy for oversight of dual-use research of concern and pathogens with enhanced pandemic potential (PEPP) focuses on federally funded research projects that are predicted by the funding applicant to have a nontrivial likelihood of generating a PEPP. This leaves a considerable gap in oversight of nonfederally funded work and research on novel pathogens. The prediction of pandemic risk arising from novel experiments is difficult even for multidisciplinary teams of experts, and a self-reporting system is inadequate as evidenced by past incidents. Creating an independent organization for oversight, inspection, and investigation of research projects regardless of funding source will ensure consistency and transparency in policy implementation and help to build knowledge and best practices for mitigating the risks of accidental outbreaks.

Indexed as

lab-based outbreaksoversightpandemic riskpathogen enhancementPEPP

Identifiers

PMID40548086
PMCPMC12179365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.